Exosomes derived from maxillary BMSCs enhanced the osteogenesis in iliac BMSCs

Area of Science:

• Regenerative Medicine
• Biotechnology
• Oral and Maxillofacial Surgery

Background:

• Secondary alveolar bone grafting is crucial for treating alveolar cleft deformities.
• Autologous iliac bone is a preferred grafting source, but factors influencing bone formation remain unclear.
• Investigating the role of the jaw bone niche and its mesenchymal stem cells (BMSCs-J) on iliac bone marrow mesenchymal stem cells (BMSCs-I) is essential.

Purpose of the Study:

• To determine if jaw bone marrow mesenchymal stem cells (BMSCs-J) influence the osteogenesis of iliac bone marrow mesenchymal stem cells (BMSCs-I).
• To elucidate the mechanism by which BMSCs-J affect BMSCs-I osteogenic capacity.

Main Methods:

• Co-culture models were used to assess the interaction between BMSCs-J and BMSCs-I.
• Exosomes were isolated from BMSCs using sequential centrifugation.
• Osteoblastic differentiation was analyzed in vitro and in vivo, with exosome function assessed using siRNA for Rab27a.

Main Results:

• Co-culturing BMSCs-I with BMSCs-J significantly increased alkaline phosphatase activity, Alizarin Red S staining, and osteogenic gene expression in BMSCs-I.
• Exosomes secreted by BMSCs-J were confirmed and found to enhance osteogenesis in BMSCs-I both in vitro and in vivo.
• Inhibition of exosome secretion via Rab27a siRNA blocked the osteogenic enhancement effect of BMSCs-J.

Conclusions:

• Exosomes mediate the interaction between jaw bone and iliac bone mesenchymal stem cells.
• BMSCs-J-derived exosomes enhance the osteogenic capacity of BMSCs-I, promoting new bone formation.
• This finding highlights the therapeutic potential of exosomes in alveolar bone grafting and regenerative medicine.